Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
Apr 21, 2026 - 01:10:08
Radio and PodcastLive Radio & PodcastsNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Ep190: Neil Kumar on Building a Rare Disease Drug Company is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman. Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease dru...
This episode belongs to The Long Run with Luke Timmerman.
Use the player on this page to stream the episode online.
Published Nov 20, 2025, 01:13:12 long, audio available.
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
You can listen to Ep190: Neil Kumar on Building a Rare Disease Drug Company online on Radio and Podcast. Open the player on this page to stream the available audio.
Ep190: Neil Kumar on Building a Rare Disease Drug Company is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
This episode is 01:13:12 long.
This episode was published on Nov 20, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Long Run with Luke Timmerman when more episodes are available from the podcast feed.
You can listen to Ep190: Neil Kumar on Building a Rare Disease Drug Company on this page when the episode audio is available from the podcast feed.
Ep190: Neil Kumar on Building a Rare Disease Drug Company is from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
Published Nov 20, 2025 and 01:13:12 long